US House votes to end Iran war, 7 Republicans join in favour

The US House passed a 220-204 war-powers resolution to restrict further US military action in Iran without congressional authorization, with seven Republicans joining Democrats. The measure is unlikely to become law because it has not cleared the full legislative process and President Trump would likely veto it. A CBO report estimates the six-month conflict has cost $38 billion, will add roughly $3 billion per month, and could raise inflation by 0.5 percentage points in the first three months of 2027, while also straining US munitions inventories.

Analysis

The vote is not itself a de-escalation catalyst; absent a veto-proof congressional outcome or a verified reduction in operational tempo, defense and energy-risk premia should not be marked down materially. The more investable implication is political: a widening intra-party split raises the probability that FY2027 supplemental appropriations become more contentious, shifting defense beneficiaries from broad platform primes toward firms with funded backlog and high consumables exposure. RTX, LMT and NOC retain near-term munitions leverage, while HII and GD face relatively greater risk if procurement emphasis shifts from force projection to replenishment and missile defense.

Over the next 1-3 months, the clearest transmission channel is inflation expectations rather than a direct earnings revision. Persistent military outlays and regional supply disruption can steepen the Treasury curve, pressuring long-duration equities and rate-sensitive infrastructure; TIP versus IEF is the cleaner macro expression than a broad equity short. Conversely, any credible ceasefire process would likely compress the geopolitical oil premium quickly, hurting XLE relative to airlines and transports, but that outcome requires observable operational evidence rather than legislative messaging.

Consensus may overstate the significance of a symbolic war-powers vote while understating election-driven policy volatility. Defense multiples could compress even if revenues rise if investors begin pricing delayed appropriations, margin caps, or procurement scrutiny; backlog conversion and free-cash-flow guidance matter more than headline contract awards. Falsification for the inflation/term-premium thesis would be a sustained decline in breakevens and crude alongside evidence of reduced deployment, while a supplemental funding package with broad bipartisan support would remove the appropriations-risk leg.

Key Decisions for Investors

• Maintain, rather than add to, broad defense exposure after the vote; favor RTX and LMT over HII and GD for the next 1-3 months, contingent on quarterly backlog conversion and FCF guidance. Exit the relative trade if supplemental appropriations explicitly prioritize naval/platform procurement or RTX/LMT cut delivery guidance.
• Establish a modest long TIP / short IEF relative-value position over 1-3 months to express elevated inflation and term-premium risk; target a 3-5% relative move, with a stop if 10-year breakevens decline 20bp and energy prices fall materially on verified de-escalation.
• Do not short XLE solely on congressional action. Set an alert for independently confirmed cessation of major operations or a durable ceasefire framework; on that catalyst, consider short XLE versus long JETS for a 1-3 month geopolitical-risk-premium unwind, with risk capped if crude reclaims its pre-ceasefire high.
• Ahead of defense earnings, watch funded backlog, missile/interceptor production rates, and working-capital commentary rather than announced awards. A missed FCF conversion target would be a more actionable short catalyst for individual primes than the legislative headline.